NewsWorld
PredictionsDigestsScorecardTimelinesArticles
NewsWorld
HomePredictionsDigestsScorecardTimelinesArticlesWorldTechnologyPoliticsBusiness
AI-powered predictive news aggregation© 2026 NewsWorld. All rights reserved.
Trending
MilitaryCrisisStrikesFebruaryDiplomaticTrumpOscarNewsDigestTimelineTariffsIranBestWinFundingInfrastructureAdditionalClimateTrump'sGreenlandDaysAnnouncesIranianMajor
MilitaryCrisisStrikesFebruaryDiplomaticTrumpOscarNewsDigestTimelineTariffsIranBestWinFundingInfrastructureAdditionalClimateTrump'sGreenlandDaysAnnouncesIranianMajor
All Articles
Private Equity Returns Slump for Fourth Straight Year
Bloomberg
Clustered Story
Published about 4 hours ago

Private Equity Returns Slump for Fourth Straight Year

Bloomberg · Feb 23, 2026 · Collected from RSS

Summary

Private equity returned fewer profits to investors for a fourth straight year as the industry sat on $3.8 trillion of unsold assets and struggled to raise money for new funds. Allison McNeely reports. (Source: Bloomberg)


Share this story

Read Original at Bloomberg

Related Articles

Bloombergabout 17 hours ago
Private Equity’s Dry Spell Now Worse Than 2008 Crisis, Bain Says

Private equity returned fewer profits to investors for a fourth straight year as the industry sat on $3.8 trillion of unsold assets and struggled to raise money for new funds.

Bloomberg34 minutes ago
KKR-Backed Global Medical Response Said to Pick Banks for US IPO

Global Medical Response has selected banks for an initial public offering, according to people familiar with the matter, as the KKR & Co.-backed air and ground emergency medical services company joins a growing list of firms seeking to tap investors.

Bloomberg40 minutes ago
Stocks Fall as Software Weakness, Tariff Risks Weigh | Closing Bell

Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Kristine Aquino, Carol Massar and Emily Graffeo. (Source: Bloomberg)

Bloombergabout 1 hour ago
Canadian Drugmaker Apotex Seeks Up to $730 Million in First-Half IPO

Canadian generic drug manufacturer Apotex Inc. is looking at the first half of the year for an initial public offering in Toronto that could raise as much as C$1 billion ($730 million), according to people familiar with the matter.

Bloombergabout 1 hour ago
Active ETF Market Too Big to Ignore: Spence

Travis Spence, Global Head of ETF at JPMorgan Asset Management joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ" to discuss the intensifying race to bring actively managed ETFs to market. (Source: Bloomberg)

Bloombergabout 1 hour ago
Test Your ETF Knowledge in Our IQ Test

Bloomberg's Joel Weber puts Scarlet Fu and Eric Balchunas to the test on "Bloomberg ETF IQ" in this week's edition of "IQ Test." (Source: Bloomberg)